Yuwei Da
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Da, yuwei
NCT05092841: A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A

Completed
3
176
RoW
PXT3003, (RS)-baclofen, naltrexone hydrochloride and D-sorbitol oral fixed dose combination, PXT3003 placebo, liquid oral solution
Tasly GeneNet Pharmaceuticals Co., Ltd
Charcot-Marie-Tooth Type 1A
03/24
03/24
NCT04101578: Clinical Prognosis and Progression of Myasthenia Gravis Patients

Recruiting
N/A
2000
RoW
Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg), Pyridostigmine Bromide, Prednisone, Methylprednisolone, Azathioprine, Tacrolimus, Cyclosporin A, Cyclophosphamide, Mycophenolate Mofetil, Methotrexate
Da, Yuwei, M.D.
Myasthenia Gravis
06/23
12/24
NCT06241521: Myasthenia Gravis Registry in China

Recruiting
N/A
1500
RoW
Huashan Hospital, China Alliance for Rare Diseases, National Center for Neurological Disorders (China), China myasthenia gravis collaborating group (CMGCG)
Myasthenia Gravis
02/34
01/35
NCT04768465 / 2020-002567-57: Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis

Recruiting
N/A
160
RoW
Pyridostigmine, Prednisone, Tacrolimus, Pyridostigmine Bromide, Deltacortone/Meticorten/Prednisone Acetate Tablets, Prograf/FK506, Pyridostigmine, Tacrolimus
Da, Yuwei, M.D., University of Oxford
Myasthenia Gravis
12/23
10/24

Download Options